A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Bipolar I disorders; Manic episodes
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 31 Aug 2018 Biomarkers information updated
- 08 Nov 2017 Planned End Date changed from 1 Nov 2018 to 1 Jan 2019.
- 08 Nov 2017 Planned primary completion date changed from 1 Nov 2018 to 1 Jan 2019.